4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002121
Chief Commercial Officer acquired 500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Oliver Tracie Chief Commercial Officer | 2023-01-04 | Grant or award | +500 | 70,500 | D |
Loading xslF345X03/doc4.xml…